{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:50:42Z","timestamp":1783774242411,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ando.2012.04.002","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T21:47:21Z","timestamp":1335390441000},"page":"111-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treatment of nonfunctioning pituitary adenomas: What were the contributions of the last 10 years? A critical view"],"prefix":"10.1016","volume":"73","author":[{"given":"Alberto M.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ando.2012.04.002_bib0005","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/jc.2005-2552","article-title":"Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma","volume":"91","author":"Dekkers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2012.04.002_bib0010","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0002-9394(00)00539-0","article-title":"Stages of improvement in visual fields after pituitary tumor resection","volume":"130","author":"Kerrison","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ando.2012.04.002_bib0015","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.2008-0643","article-title":"Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2012.04.002_bib0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/edrv-13-2-220","article-title":"Dopamine agonists and pituitary tumor shrinkage","volume":"13","author":"Bevan","year":"1992","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ando.2012.04.002_bib0025","first-page":"1310","article-title":"Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro","volume":"75","author":"de Bruin","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2012.04.002_bib0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000091573","article-title":"Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas","volume":"34","author":"Frank","year":"2006","journal-title":"Front Horm Res"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2006-932126","article-title":"Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience","volume":"49","author":"Rudnik","year":"2006","journal-title":"Minim Invasive Neurosurg"},{"issue":"3","key":"10.1016\/j.ando.2012.04.002_bib0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jocn.2007.03.008","article-title":"Endoscopic endonasal transsphenoidal surgery for invasive pituitary adenoma","volume":"15","author":"Zhang","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jocn.2010.04.049","article-title":"Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma","volume":"18","author":"Nakao","year":"2011","journal-title":"J Clin Neurosci"},{"issue":"5","key":"10.1016\/j.ando.2012.04.002_bib0050","first-page":"1006","article-title":"Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series","volume":"62","author":"Dehdashti","year":"2008","journal-title":"Neurosurgery"},{"issue":"7","key":"10.1016\/j.ando.2012.04.002_bib0055","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/lary.20949","article-title":"Microscopic versus endoscopic pituitary surgery: a systematic review","volume":"120","author":"Rotenberg","year":"2010","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.ando.2012.04.002_bib0060","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.neuchi.2009.05.003","article-title":"Endoscopy versus microsurgery: results in a consecutive series of nonfunctioning pituitary adenomas","volume":"55","author":"Kassis","year":"2009","journal-title":"Neurochirurgie"},{"issue":"4","key":"10.1016\/j.ando.2012.04.002_bib0065","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2011.1.FOCUS10308","article-title":"Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal","volume":"30","author":"Messerer","year":"2011","journal-title":"Neurosurg Focus"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3171\/2011.2.JNS10566","article-title":"Endocrinological outcome after pituitary transposition (hypophysopexy) and adjuvant radiotherapy for tumours involving the cavernous sinus","volume":"115","author":"Taussky","year":"2011","journal-title":"J Neurosurg"},{"issue":"5 Suppl.","key":"10.1016\/j.ando.2012.04.002_bib0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3171\/jns.2002.97.supplement_5.0408","article-title":"Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma","volume":"97","author":"Sheehan","year":"2002","journal-title":"J Neurosurg"},{"issue":"11","key":"10.1016\/j.ando.2012.04.002_bib0080","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1210\/jc.2002-020356","article-title":"Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas","volume":"88","author":"Swords","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2012.04.002_bib0085","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1530\/EJE-09-0493","article-title":"Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy","volume":"161","author":"Swords","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1227\/01.NEU.0000068702.00330.47","article-title":"Gamma knife radiosurgery for pituitary adenoma: early results","volume":"53","author":"Petrovich","year":"2003","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.ando.2012.04.002_bib0095","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1227\/01.NEU.0000088661.81189.66","article-title":"Stereotactic radiosurgery as an alternative to fractionated radiotherapy for patients with recurrent or residual nonfunctioning pituitary adenomas","volume":"53","author":"Pollock","year":"2003","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.ando.2012.04.002_bib0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-2004-830261","article-title":"Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas","volume":"48","author":"Kajiwara","year":"2005","journal-title":"Minim Invasive Neurosurg"},{"issue":"2","key":"10.1016\/j.ando.2012.04.002_bib0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1227\/01.NEU.0000255519.96837.C7","article-title":"Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3-year follow-up","volume":"61","author":"Pamir","year":"2007","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.ando.2012.04.002_bib0110","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ijrobp.2007.08.018","article-title":"Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience","volume":"70","author":"Pollock","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ando.2012.04.002_bib0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11102-008-0163-x","article-title":"Adjuvant Gamma Knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients","volume":"12","author":"H\u00f6ybye","year":"2009","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/j.ando.2012.04.002_bib0120","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/neuonc\/nor055","article-title":"Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity","volume":"13","author":"Iwata","year":"2011","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.ando.2012.04.002_bib0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1227\/NEU.0b013e31821bc44e","article-title":"Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma","volume":"69","author":"Gopalan","year":"2011","journal-title":"Neurosurgery"},{"issue":"10","key":"10.1016\/j.ando.2012.04.002_bib0130","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.2008-0643","article-title":"The natural course of non-functioning pituitary macroadenomas","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2012.04.002_bib0135","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2007.02990.x","article-title":"What is the natural history of nonoperated nonfunctioning pituitary adenomas?","volume":"67","author":"Karavitaki","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ando.2012.04.002_bib0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1017\/S0317167100051532","article-title":"Conservative management of pituitary macroadenoma contacting the optic apparatus","volume":"37","author":"Ryu","year":"2010","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","article-title":"Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis","volume":"15","author":"Roelfsema","year":"2012","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.ando.2012.04.002_bib0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S0317167100002614","article-title":"P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas","volume":"30","author":"Hentschel","year":"2003","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"10.1016\/j.ando.2012.04.002_bib0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3171\/jns.2003.98.2.0359","article-title":"Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index","volume":"98","author":"Tanaka","year":"2003","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.ando.2012.04.002_bib0160","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1530\/EJE-09-1100","article-title":"MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma","volume":"162","author":"Hsu","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ando.2012.04.002_bib0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3171\/2008.4.17517","article-title":"Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression","volume":"111","author":"Widhalm","year":"2009","journal-title":"Neurosurg"},{"issue":"2","key":"10.1016\/j.ando.2012.04.002_bib0170","first-page":"72","article-title":"Non-functioning pituitary adenoma: immunohistochemical analysis of 85 cases","volume":"45","author":"Mahta","year":"2007","journal-title":"Folia Neuropathol"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53","volume":"94","author":"Kasuki Jomori de Pinho","year":"2011","journal-title":"Neuroendocrinology"},{"issue":"7","key":"10.1016\/j.ando.2012.04.002_bib0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jocn.2005.03.010","article-title":"Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas","volume":"12","author":"Liu","year":"2005","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0185","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2353\/ajpath.2007.060736","article-title":"Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line","volume":"170","author":"Hussaini","year":"2007","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.ando.2012.04.002_bib0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2265.2006.02735.x","article-title":"A mutation and expression analysis of the oncogene BRAF in pituitary adenomas","volume":"66","author":"Ewing","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2012.04.002_bib0195","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1210\/jc.2003-030222","article-title":"A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells","volume":"88","author":"Zhang","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ando.2012.04.002_bib0200","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1210\/jc.2007-2633","article-title":"Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3\/DLK1 locus in human clinically nonfunctioning pituitary adenomas","volume":"93","author":"Gejman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2012.04.002_bib0205","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/cncr.24053","article-title":"O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?","volume":"115","author":"Widhalm","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jocn.2011.07.029","article-title":"Overexpression of the Notch3 receptor in non-functioning pituitary tumours","volume":"19","author":"Miao","year":"2012","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.ando.2012.04.002_bib0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/eje.1.02313","article-title":"Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas","volume":"156","author":"Taboada","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ando.2012.04.002_bib0220","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.lfs.2005.05.061","article-title":"The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin\/dopamine (SST\/DA) chimera and bromocriptine on the \u201cclinically non-functioning\u201d pituitary adenomas in vitro","volume":"78","author":"Gruszka","year":"2006","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.ando.2012.04.002_bib0225","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/ERC-07-0271","article-title":"Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study","volume":"15","author":"Florio","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.ando.2012.04.002_bib0230","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1210\/jc.2003-030859","article-title":"Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.ando.2012.04.002_bib0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.mce.2007.12.011","article-title":"Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas","volume":"286","author":"Padova","year":"2008","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.ando.2012.04.002_bib0240","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/0008-5472.CAN-09-2951","article-title":"The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells","volume":"70","author":"Cerovac","year":"2010","journal-title":"Cancer Res"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426612000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426612000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:44:43Z","timestamp":1757717083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426612000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0003426612000662"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2012.04.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of nonfunctioning pituitary adenomas: What were the contributions of the last 10years? A critical view","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2012.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}